Home / Pharmaceutical company intelligence
Don Valley logo
Pharmaceutical company intelligence

Don Valley

Pharmaceutical manufacturer and contract manufacturer · Lahore · Pakistan

Lahore-based generic and contract pharmaceutical manufacturer producing multiple dosage forms including penicillins, cephalosporins, injectables, solids, liquids and nutraceuticals.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation22 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date27 Jul 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
Don Valley Pharmaceuticals
Company type
Pharmaceutical manufacturer and contract manufacturer
Address
31-KM Main Ferozepur Road, Lahore 54000, Pakistan · 54000
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
75%
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000395 144 linked products · source seen 22 Sep 2026 View source ↗
Corporate profile source ledger Logo Url source ↗ Contact Page Url source ↗ Logo Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx145public portfolio records represented
REG90unique registrations represented
IDX143indexed MedInfoBase presentations
SRC2additional source-observed presentations
R+0registry-only registrations
VER0registry-verified exact registrations
PKR125current validated price records
G40generic molecules in indexed catalogue
DF8dosage-form groups
TA11therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage86%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage96%
priced packs safely normalized per unit
Comparable-market coverage93%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixDon ValleyShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/don-valleyGenerated 22 Sep 2026Anti-infectives76 · 53%Pain & musculoskeletal18 · 13%CNS & mental health12 · 8%Cardiovascular12 · 8%Hematology & thrombosis8 · 6%Respiratory & allergy5 · 3%Vitamins, minerals & nutrition4 · 3%Other therapeutic areas8 · 6%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioDon ValleyDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/don-valleyGenerated 22 Sep 2026143presentationsTablet77 · 54%Suspension28 · 20%Capsule19 · 13%Syrup9 · 6%Injection6 · 4%Lotion2 · 1%Other forms2 · 1%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionDon ValleyCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/don-valleyGenerated 22 Sep 2026133comparable productsBelow peer median33 · 25%Near peer median48 · 36%Above peer median52 · 39%Company median price position+2.1%Lowest-price equivalents6Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsDon ValleyCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/don-valleyGenerated 22 Sep 2026Mediate Pharmaceutical Pvt Ltd28 shared70% overlapNabiqasim Industries (Pvt) Ltd.,26 shared65% overlapMacter International Limited26 shared65% overlapWerrick Pharmaceuticals24 shared60% overlapZafa Pharmaceutical Laboratories (P…24 shared60% overlapAtco Laboratories Limited23 shared58% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives76 products · 53%
Pain & musculoskeletal18 products · 13%
CNS & mental health12 products · 8%
Cardiovascular12 products · 8%
Hematology & thrombosis8 products · 6%
Respiratory & allergy5 products · 3%
Vitamins, minerals & nutrition4 products · 3%
Gastrointestinal & hepatology4 products · 3%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Penicillin antibacterials18 products · 13%
Analgesics / NSAIDs18 products · 13%
Third-generation cephalosporins13 products · 9%
Macrolide antibacterials11 products · 8%
Fluoroquinolone antibacterials9 products · 6%
Anticoagulants7 products · 5%
Antimalarials6 products · 4%
Antivirals5 products · 3%
Formulation footprint

Dosage forms

Tablet77 products
Suspension28 products
Capsule19 products
Syrup9 products
Injection6 products
Lotion2 products
Drops1 products
Ointment1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 AmoxicapAmoxicillin 10presentations 125 mg/5 mL, 250 mg, 250 mg/5 mL, 500 mg · Suspension, Capsule #2 TylolParacetamol 9presentations 120 mg/5 mL, 500 mg · Suspension, Tablet #3 CefidonCefixime 7presentations 100 mg/5 mL, 200 mg, 200 mg/5 mL, 400 mg · Suspension, Capsule #4 DV-ZythroAzithromycin 7presentations 200 mg/5 mL, 250 mg, 500 mg · Suspension, Tablet #5 DV-CefCeftriaxone 6presentations 1 g, 250 MG, 250 mg, 500 mg · Injection #6 IbtolIbuprofen 6presentations 100 mg/5 mL, 200 mg, 400 mg · Suspension, Tablet
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median3325% of comparable products
Near market median48within ±5% of median
Above market median5239% of comparable products
Lowest-price equivalents6ties included
Company median price position +2.1% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Devomycin 250 mgOxytetracycline · Capsule · 1's PKR 3.19/capsule-37.9% vs market median Empadon 10 mgEmpagliflozin · Tablet · 14's PKR 53.77/tablet-34.9% vs market median Angepine XR 300 mgQuetiapine · Extended-release tablet · 30’s PKR 91.43/tablet-33.0% vs market median Rofedon 600 mgRibavirin · Tablet · 100's PKR 16.57/tablet-32.7% vs market median Leptil 500 mgSodium valproate · Tablet · 50's PKR 8.64/tablet-31.5% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Mediate Pharmaceutical Pvt Ltd236 products · 90 generics 28shared generics Nabiqasim Industries (Pvt) Ltd.,365 products · 118 generics 26shared generics Macter International Limited256 products · 93 generics 26shared generics Werrick Pharmaceuticals249 products · 82 generics 24shared generics Zafa Pharmaceutical Laboratories (Pvt) Ltd.245 products · 97 generics 24shared generics Atco Laboratories Limited278 products · 94 generics 23shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers89Distinct registrations among indexed, published, presentation-validated products only
Verified price observations144
Products with a verified price143
Products with multiple price observations1
Source records with multiple versions139
Latest portfolio source check22 Sep 2026
Latest effective price date27 Jul 2026
Latest source observation22 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

90 unique registration(s) · 143 indexed presentation(s) · 2 additional source-observed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Lovenox Levofloxacin 250 mg Tablet 10's 069370 PKR 485.37 PKR 48.54/tablet Near median
Lovenox Levofloxacin 500 mg Tablet 100's 069371 PKR 7,753.44 PKR 77.53/tablet Near median
Lovenox Levofloxacin 500 mg Tablet 10's 069371 PKR 807.65 PKR 80.77/tablet Near median
Macrocid Clarithromycin 250 mg Tablet 10's 019771 PKR 710.81 PKR 71.08/tablet 49% above median
Macrocid Clarithromycin 125 mg/5 mL Suspension 60ml 019772 PKR 432.95 PKR 7.22/mL Near median
Macrocid Clarithromycin 250 MG/5 mL Suspension 60ml 095669 PKR 729.42 PKR 12.16/mL Near median
Macrocid Clarithromycin 500 mg Tablet 10's 101872 PKR 738.63 PKR 73.86/tablet 12% below median
Opicap Omeprazole 20 mg Capsule 14's 028001 PKR 339.76 PKR 24.27/capsule 23% above median
Opicap Omeprazole 20 mg Capsule 10's 028001 PKR 155.32 PKR 15.53/capsule 21% below median
Opicap Omeprazole 20 mg Capsule 100's 028001 PKR 1,491.07 PKR 14.91/capsule 24% below median
Resotin Loratadine 10 mg Tablet 500's 020290 PKR 10,879.72 PKR 21.76/tablet 52% above median
Resotin Loratadine 10 mg Tablet 10's 020290 PKR 257.64 PKR 25.76/tablet 80% above median
Rivadon Rivaroxaban 20 mg Tablet 7's 098496 PKR 6,576.18 PKR 939.45/tablet 5% above median
Rivadon Rivaroxaban 20 mg Tablet 10's 098496 PKR 8,924.90 PKR 892.49/tablet Near median
Rivadon Rivaroxaban 20 mg Tablet 14's 098496 PKR 12,496.18 PKR 892.58/tablet Near median
Rivadon Rivaroxaban 10 mg Tablet 30's 106974 PKR 16,228.33 PKR 540.94/tablet Near median
Rivadon Rivaroxaban 10 mg Tablet 10's 106974 PKR 5,522.14 PKR 552.21/tablet Near median
Rofedon Ribavirin 600 mg Tablet 20's 103627 PKR 342.15 PKR 17.11/tablet 30% below median
Rofedon Ribavirin 600 mg Tablet 10's 103627 PKR 180.08 PKR 18.01/tablet 27% below median
Rofedon Ribavirin 600 mg Tablet 100's 103627 PKR 1,656.75 PKR 16.57/tablet 33% below median
Rofedon Ribavirin 400 mg Tablet 10's 103628 PKR 135.06 PKR 13.51/tablet 25% below median
Scaric Lotion Benzyl benzoate 25 % Lotion 60ml 023707 PKR 40.83 PKR 0.68/mL 21% above median
Scaric Lotion Benzyl benzoate 25 % Lotion 120ml 023707 PKR 67.25 PKR 0.56/mL 18% below median
Sulforin Sulfamethoxazole + Trimethoprim 200 mg + 40 mg / 5 mL Suspension 100ml 023703 PKR 65.09 PKR 0.65/mL 13% below median
Sulforin Sulfamethoxazole + Trimethoprim 200 mg/5 mL + 40 mg/5 mL Suspension 50ml 023703 PKR 35.64 PKR 0.71/mL No comparator
Sulforin DS Sulfamethoxazole + Trimethoprim 800 mg + 160 mg Tablet 100's 023536 PKR 969.34 PKR 9.69/tablet Near median
Tylol Paracetamol 500 mg Tablet 30's 019768 PKR 114.44 PKR 3.81/tablet 5% above median
Tylol Paracetamol 500 mg Tablet 100's 019768 PKR 381.46 PKR 3.81/tablet 5% above median
Tylol Paracetamol 500 mg Tablet 1000's 019768 PKR 3,661.77 PKR 3.66/tablet Near median
Tylol Paracetamol 500 mg Tablet 20's 019768 PKR 76.29 PKR 3.81/tablet 5% above median
Tylol Paracetamol 500 mg Tablet 200's 019768 PKR 762.93 PKR 3.81/tablet 5% above median
Tylol Paracetamol 120 mg/5 mL Suspension 90ml 019770 PKR 87.62 PKR 0.97/mL 7% below median
Tylol Paracetamol 120 mg/5 mL Suspension 100ml 019770 PKR 114.97 PKR 1.15/mL 10% above median
Tylol Paracetamol 120 mg/5 mL Suspension 120ml 019770 PKR 114.73 PKR 0.96/mL 9% below median
Tylol Paracetamol 120 mg/5 mL Suspension 60ml 019770 PKR 68.99 PKR 1.15/mL 10% above median
TylolSource observed Paracetamol 80 mg/0.8 mL Held for normalizationSource reported: Tablet · structural field conflict 15ml 020292Official source ↗ No indexed price — —
Tylol 6 Plus Paracetamol 250 MG/5 mL Suspension 90ml 022101 PKR 105.05 PKR 1.17/mL 24% below median
Tylol 6 Plus Paracetamol 250 mg/5 mL Suspension 100ml 022101 PKR 109.02 PKR 1.09/mL 29% below median
Tylol 6 Plus Paracetamol 250 MG/5 mL Suspension 60ml 022101 PKR 94.97 PKR 1.58/mL Near median
Tylol Drops Paracetamol 80mg/0.8mlSource observed — — — 15ml 020292Official source ↗ No indexed price — —
Ulsive Omeprazole 20 mg Tablet 14's 029016 PKR 421.11 PKR 30.08/tablet 58% above median
Vilobet Ointment Calcipotriol 50 mcg/g Ointment 30 gm 109634 PKR 1,678.58 PKR 55.95/g 14% above median
Virtec Cetirizine 10 mg Tablet 500's 021870 PKR 4,211.27 PKR 8.42/tablet 6% above median
Virtec Cetirizine 10 mg Tablet 10's 021870 PKR 87.73 PKR 8.77/tablet 10% above median
Virtec Cetirizine 10 mg Tablet 200's 021870 PKR 1,684.50 PKR 8.42/tablet 6% above median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Don Valley — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 22, 2026, from https://medinfobase.com/company/don-valley/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.